

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.27110606 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 7.85399811 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 7.61812745 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.56579809 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.56579809 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.23887725 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.23887725 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.81419204 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.41894048 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.15793789 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.15793789 |
| 12 | tryptophan catabolic process (GO:0006569) | 6.15793789 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.03953032 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.95906585 |
| 15 | drug metabolic process (GO:0017144) | 5.83214433 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.81461900 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.79923031 |
| 18 | urea metabolic process (GO:0019627) | 5.73251638 |
| 19 | urea cycle (GO:0000050) | 5.73251638 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.72341631 |
| 21 | oxidative demethylation (GO:0070989) | 5.67418046 |
| 22 | regulation of protein activation cascade (GO:2000257) | 5.58432979 |
| 23 | complement activation, alternative pathway (GO:0006957) | 5.57539639 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.50175489 |
| 25 | protein carboxylation (GO:0018214) | 5.48265763 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.48265763 |
| 27 | * negative regulation of fibrinolysis (GO:0051918) | 5.36066357 |
| 28 | cysteine metabolic process (GO:0006534) | 5.33829054 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 5.32656073 |
| 30 | * regulation of fibrinolysis (GO:0051917) | 5.28000611 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.26474601 |
| 32 | regulation of complement activation (GO:0030449) | 5.19546000 |
| 33 | phenylpropanoid metabolic process (GO:0009698) | 5.08424279 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 5.07775649 |
| 35 | bile acid metabolic process (GO:0008206) | 5.07351218 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 5.02514267 |
| 37 | reverse cholesterol transport (GO:0043691) | 5.02418625 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 4.95190518 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 4.94568034 |
| 40 | ethanol metabolic process (GO:0006067) | 4.93050619 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.91880387 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.91880387 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.91880387 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.88208935 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.79965483 |
| 46 | homocysteine metabolic process (GO:0050667) | 4.74387774 |
| 47 | phospholipid efflux (GO:0033700) | 4.72601453 |
| 48 | * negative regulation of hemostasis (GO:1900047) | 4.71105369 |
| 49 | * negative regulation of blood coagulation (GO:0030195) | 4.71105369 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.69232615 |
| 51 | acylglycerol homeostasis (GO:0055090) | 4.69232615 |
| 52 | regulation of humoral immune response (GO:0002920) | 4.63554848 |
| 53 | alpha-amino acid catabolic process (GO:1901606) | 4.61273738 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.60026594 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 4.60026594 |
| 56 | lysine catabolic process (GO:0006554) | 4.57535772 |
| 57 | lysine metabolic process (GO:0006553) | 4.57535772 |
| 58 | amino-acid betaine metabolic process (GO:0006577) | 4.56239579 |
| 59 | intestinal cholesterol absorption (GO:0030299) | 4.55481483 |
| 60 | plasma lipoprotein particle clearance (GO:0034381) | 4.51880080 |
| 61 | S-adenosylmethionine metabolic process (GO:0046500) | 4.40423116 |
| 62 | glycine metabolic process (GO:0006544) | 4.39524185 |
| 63 | bile acid and bile salt transport (GO:0015721) | 4.38599967 |
| 64 | indolalkylamine metabolic process (GO:0006586) | 4.36347692 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 4.36301520 |
| 66 | cholesterol efflux (GO:0033344) | 4.34667726 |
| 67 | coenzyme catabolic process (GO:0009109) | 4.32760789 |
| 68 | * negative regulation of coagulation (GO:0050819) | 4.29024505 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 4.27294124 |
| 70 | cellular biogenic amine catabolic process (GO:0042402) | 4.26634402 |
| 71 | amine catabolic process (GO:0009310) | 4.26634402 |
| 72 | cellular amino acid catabolic process (GO:0009063) | 4.23906153 |
| 73 | * negative regulation of wound healing (GO:0061045) | 4.22003988 |
| 74 | glutamate metabolic process (GO:0006536) | 4.20913958 |
| 75 | cellular glucuronidation (GO:0052695) | 4.18626617 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 4.16773956 |
| 77 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.14038559 |
| 78 | plasma lipoprotein particle assembly (GO:0034377) | 4.13556452 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 4.13185264 |
| 80 | alkaloid metabolic process (GO:0009820) | 4.11823291 |
| 81 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.05106304 |
| 82 | arginine metabolic process (GO:0006525) | 4.04127561 |
| 83 | low-density lipoprotein particle remodeling (GO:0034374) | 4.03895801 |
| 84 | cellular modified amino acid catabolic process (GO:0042219) | 4.03615902 |
| 85 | daunorubicin metabolic process (GO:0044597) | 4.02295058 |
| 86 | polyketide metabolic process (GO:0030638) | 4.02295058 |
| 87 | doxorubicin metabolic process (GO:0044598) | 4.02295058 |
| 88 | aldehyde catabolic process (GO:0046185) | 4.02217066 |
| 89 | blood coagulation, intrinsic pathway (GO:0007597) | 4.00911361 |
| 90 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.00695372 |
| 91 | serine family amino acid biosynthetic process (GO:0009070) | 3.99779376 |
| 92 | ethanol oxidation (GO:0006069) | 3.99227534 |
| 93 | hormone catabolic process (GO:0042447) | 3.96149424 |
| 94 | drug catabolic process (GO:0042737) | 3.94256584 |
| 95 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.92585964 |
| 96 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.92585964 |
| 97 | complement activation, classical pathway (GO:0006958) | 3.89446777 |
| 98 | * regulation of plasminogen activation (GO:0010755) | 3.89044777 |
| 99 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.88441121 |
| 100 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.88441121 |
| 101 | protein activation cascade (GO:0072376) | 3.85439962 |
| 102 | flavonoid metabolic process (GO:0009812) | 3.84873762 |
| 103 | complement activation (GO:0006956) | 3.84863451 |
| 104 | negative regulation of lipase activity (GO:0060192) | 3.83062045 |
| 105 | cofactor catabolic process (GO:0051187) | 3.82640758 |
| 106 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.82432729 |
| 107 | response to mercury ion (GO:0046689) | 3.82374618 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 3.81628720 |
| 109 | phospholipid homeostasis (GO:0055091) | 3.80867944 |
| 110 | * fibrinolysis (GO:0042730) | 3.80206264 |
| 111 | cholesterol homeostasis (GO:0042632) | 3.78342357 |
| 112 | cytolysis (GO:0019835) | 3.78200124 |
| 113 | ketone body metabolic process (GO:1902224) | 3.77460132 |
| 114 | acute-phase response (GO:0006953) | 3.75809997 |
| 115 | plasma lipoprotein particle organization (GO:0071827) | 3.73561066 |
| 116 | * positive regulation of hemostasis (GO:1900048) | 3.73267986 |
| 117 | * positive regulation of blood coagulation (GO:0030194) | 3.73267986 |
| 118 | sterol homeostasis (GO:0055092) | 3.72169888 |
| 119 | negative regulation of complement activation (GO:0045916) | 3.71519841 |
| 120 | uronic acid metabolic process (GO:0006063) | 3.71363913 |
| 121 | glucuronate metabolic process (GO:0019585) | 3.71363913 |
| 122 | protein-lipid complex assembly (GO:0065005) | 3.71017279 |
| 123 | organic acid catabolic process (GO:0016054) | 3.70161345 |
| 124 | carboxylic acid catabolic process (GO:0046395) | 3.70161345 |
| 125 | heme transport (GO:0015886) | 3.68318426 |
| 126 | regulation of bile acid biosynthetic process (GO:0070857) | 3.67834312 |
| 127 | negative regulation of protein activation cascade (GO:2000258) | 3.64884121 |
| 128 | opsonization (GO:0008228) | 3.63844613 |
| 129 | acetyl-CoA metabolic process (GO:0006084) | 3.63234945 |
| 130 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.57791597 |
| 131 | acute inflammatory response (GO:0002526) | 3.53833012 |
| 132 | regulation of apoptotic cell clearance (GO:2000425) | 3.53468322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.39291313 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.20434035 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.13509168 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.49388268 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.29809229 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.16758228 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.83800809 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.09094094 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.00578393 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07638366 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.00882032 |
| 12 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0166961 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97580973 |
| 14 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61457879 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57317730 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57036839 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47006019 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41469884 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27894999 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.24477375 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21466553 |
| 22 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20979405 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18409112 |
| 24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.14021952 |
| 25 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01395764 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99349909 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96402141 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95668995 |
| 29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91802148 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.91217042 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89584427 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.87205638 |
| 33 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84334285 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81676185 |
| 35 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80377174 |
| 36 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80109411 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.79521293 |
| 38 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78929004 |
| 39 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78554928 |
| 40 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.77168094 |
| 41 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.76769901 |
| 42 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76758150 |
| 43 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75145017 |
| 44 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75035221 |
| 45 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74790364 |
| 46 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73794628 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.73043390 |
| 48 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71713999 |
| 49 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70625250 |
| 50 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.70274426 |
| 51 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.69715691 |
| 52 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.69060600 |
| 53 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67794099 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.67548341 |
| 55 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.66865249 |
| 56 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.65665289 |
| 57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65291802 |
| 58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65291802 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65244301 |
| 60 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.65180240 |
| 61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.63943908 |
| 62 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.63672048 |
| 63 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63438676 |
| 64 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.62394857 |
| 65 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.61333624 |
| 66 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.60352039 |
| 67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60106605 |
| 68 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59218585 |
| 69 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58720469 |
| 70 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.58171929 |
| 71 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.58159740 |
| 72 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57592938 |
| 73 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.56403375 |
| 74 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.55683868 |
| 75 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.55289058 |
| 76 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.54873014 |
| 77 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.54376371 |
| 78 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54282243 |
| 79 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54201233 |
| 80 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53785464 |
| 81 | NFYA_21822215_ChIP-Seq_K562_Human | 0.53761473 |
| 82 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53140219 |
| 83 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.52872573 |
| 84 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52737434 |
| 85 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.51983985 |
| 86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51603885 |
| 87 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.51603252 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.51540482 |
| 89 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.51151126 |
| 90 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50426868 |
| 91 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50285028 |
| 92 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.50093538 |
| 93 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.49799742 |
| 94 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.49717686 |
| 95 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.48993532 |
| 96 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.48956149 |
| 97 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.48412457 |
| 98 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47817178 |
| 99 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.47750913 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.47588447 |
| 101 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46975180 |
| 102 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.46938048 |
| 103 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.46929016 |
| 104 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46477693 |
| 105 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.46476081 |
| 106 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.45764393 |
| 107 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45682839 |
| 108 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.45599056 |
| 109 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.45531180 |
| 110 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.44190438 |
| 111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43552928 |
| 112 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42546734 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.42110841 |
| 114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.40976499 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.40847883 |
| 116 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.40610331 |
| 117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39974461 |
| 118 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.39813712 |
| 119 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39437473 |
| 120 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.38728842 |
| 121 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.38497218 |
| 122 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38490781 |
| 123 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38406387 |
| 124 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38272060 |
| 125 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38020475 |
| 126 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.36361477 |
| 127 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.36049336 |
| 128 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.35115991 |
| 129 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34837037 |
| 130 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.34801361 |
| 131 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.34709029 |
| 132 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34452382 |
| 133 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33832796 |
| 134 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.33557294 |
| 135 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.33183412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.28830721 |
| 2 | MP0005360_urolithiasis | 7.54196440 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.45940109 |
| 4 | MP0005365_abnormal_bile_salt | 6.22980862 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.07876037 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.24736182 |
| 7 | MP0003252_abnormal_bile_duct | 3.90762469 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.60826572 |
| 9 | MP0009840_abnormal_foam_cell | 3.30633942 |
| 10 | MP0005083_abnormal_biliary_tract | 3.04289623 |
| 11 | MP0003195_calcinosis | 2.78237054 |
| 12 | MP0005332_abnormal_amino_acid | 2.73728258 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.58868478 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.43632729 |
| 15 | MP0000609_abnormal_liver_physiology | 2.18413859 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.12840283 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.10125338 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.01401326 |
| 19 | MP0003868_abnormal_feces_composition | 1.93571937 |
| 20 | * MP0005319_abnormal_enzyme/_coenzyme | 1.75766728 |
| 21 | MP0001764_abnormal_homeostasis | 1.69705277 |
| 22 | MP0009697_abnormal_copulation | 1.67236142 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55969737 |
| 24 | MP0003011_delayed_dark_adaptation | 1.50955563 |
| 25 | MP0005451_abnormal_body_composition | 1.39237983 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.32022494 |
| 27 | MP0003186_abnormal_redox_activity | 1.27979816 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.23738751 |
| 29 | MP0000598_abnormal_liver_morphology | 1.19215529 |
| 30 | MP0005647_abnormal_sex_gland | 1.14202287 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.13113538 |
| 32 | MP0000604_amyloidosis | 1.11621060 |
| 33 | MP0009764_decreased_sensitivity_to | 1.06636396 |
| 34 | MP0002254_reproductive_system_inflammat | 1.04918957 |
| 35 | MP0001915_intracranial_hemorrhage | 1.02296289 |
| 36 | * MP0009763_increased_sensitivity_to | 0.99471538 |
| 37 | MP0010368_abnormal_lymphatic_system | 0.99406691 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 0.95835326 |
| 39 | * MP0008469_abnormal_protein_level | 0.88306373 |
| 40 | MP0005408_hypopigmentation | 0.88136456 |
| 41 | * MP0009642_abnormal_blood_homeostasis | 0.87310915 |
| 42 | MP0005670_abnormal_white_adipose | 0.82418588 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 0.81751881 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 0.81523474 |
| 45 | MP0005376_homeostasis/metabolism_phenot | 0.80871964 |
| 46 | MP0009765_abnormal_xenobiotic_induced | 0.78749457 |
| 47 | MP0002078_abnormal_glucose_homeostasis | 0.78266363 |
| 48 | MP0005220_abnormal_exocrine_pancreas | 0.76956604 |
| 49 | MP0002876_abnormal_thyroid_physiology | 0.75044852 |
| 50 | MP0002971_abnormal_brown_adipose | 0.71439179 |
| 51 | MP0005334_abnormal_fat_pad | 0.68509735 |
| 52 | MP0009053_abnormal_anal_canal | 0.67206396 |
| 53 | MP0000566_synostosis | 0.67036502 |
| 54 | MP0003690_abnormal_glial_cell | 0.67035851 |
| 55 | MP0001661_extended_life_span | 0.66899674 |
| 56 | MP0005535_abnormal_body_temperature | 0.66097326 |
| 57 | MP0004130_abnormal_muscle_cell | 0.65479524 |
| 58 | MP0002282_abnormal_trachea_morphology | 0.65418805 |
| 59 | MP0003879_abnormal_hair_cell | 0.65123700 |
| 60 | MP0005187_abnormal_penis_morphology | 0.64558817 |
| 61 | MP0005266_abnormal_metabolism | 0.64019653 |
| 62 | MP0000639_abnormal_adrenal_gland | 0.63342228 |
| 63 | MP0003329_amyloid_beta_deposits | 0.61885835 |
| 64 | MP0005058_abnormal_lysosome_morphology | 0.59172743 |
| 65 | MP0001756_abnormal_urination | 0.58315105 |
| 66 | MP0005464_abnormal_platelet_physiology | 0.58151279 |
| 67 | MP0006035_abnormal_mitochondrial_morpho | 0.54514829 |
| 68 | MP0005448_abnormal_energy_balance | 0.53799681 |
| 69 | MP0005395_other_phenotype | 0.52082025 |
| 70 | MP0003718_maternal_effect | 0.50943135 |
| 71 | MP0002928_abnormal_bile_duct | 0.46846004 |
| 72 | MP0002837_dystrophic_cardiac_calcinosis | 0.46236373 |
| 73 | MP0002136_abnormal_kidney_physiology | 0.44861870 |
| 74 | MP0002089_abnormal_postnatal_growth/wei | 0.44713120 |
| 75 | MP0003638_abnormal_response/metabolism_ | 0.44576756 |
| 76 | MP0003724_increased_susceptibility_to | 0.43797177 |
| 77 | MP0003436_decreased_susceptibility_to | 0.43654837 |
| 78 | MP0008874_decreased_physiological_sensi | 0.43518693 |
| 79 | MP0002822_catalepsy | 0.43395229 |
| 80 | MP0002249_abnormal_larynx_morphology | 0.42937849 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 0.40785669 |
| 82 | MP0003953_abnormal_hormone_level | 0.40547915 |
| 83 | MP0000579_abnormal_nail_morphology | 0.40094470 |
| 84 | MP0003075_altered_response_to | 0.39833501 |
| 85 | MP0005166_decreased_susceptibility_to | 0.39134708 |
| 86 | MP0005248_abnormal_Harderian_gland | 0.38330418 |
| 87 | MP0005666_abnormal_adipose_tissue | 0.37852295 |
| 88 | MP0004381_abnormal_hair_follicle | 0.37616848 |
| 89 | * MP0008873_increased_physiological_sensi | 0.37609146 |
| 90 | MP0009672_abnormal_birth_weight | 0.36489005 |
| 91 | MP0008872_abnormal_physiological_respon | 0.36415104 |
| 92 | MP0009384_cardiac_valve_regurgitation | 0.35467703 |
| 93 | MP0009115_abnormal_fat_cell | 0.33089202 |
| 94 | MP0004883_abnormal_blood_vessel | 0.32856245 |
| 95 | MP0002796_impaired_skin_barrier | 0.32707370 |
| 96 | MP0009785_altered_susceptibility_to | 0.32450334 |
| 97 | MP0000249_abnormal_blood_vessel | 0.31741760 |
| 98 | MP0001243_abnormal_dermal_layer | 0.31347823 |
| 99 | MP0002168_other_aberrant_phenotype | 0.30877903 |
| 100 | MP0002970_abnormal_white_adipose | 0.30548828 |
| 101 | MP0001881_abnormal_mammary_gland | 0.30168469 |
| 102 | MP0000230_abnormal_systemic_arterial | 0.29792192 |
| 103 | MP0001853_heart_inflammation | 0.29643358 |
| 104 | MP0006082_CNS_inflammation | 0.28796068 |
| 105 | MP0004272_abnormal_basement_membrane | 0.27377850 |
| 106 | MP0005164_abnormal_response_to | 0.27196004 |
| 107 | MP0003632_abnormal_nervous_system | 0.26696516 |
| 108 | * MP0001845_abnormal_inflammatory_respons | 0.26500054 |
| 109 | MP0000920_abnormal_myelination | 0.26487528 |
| 110 | MP0003959_abnormal_lean_body | 0.25229982 |
| 111 | MP0002060_abnormal_skin_morphology | 0.24935918 |
| 112 | MP0002132_abnormal_respiratory_system | 0.24929607 |
| 113 | MP0000427_abnormal_hair_cycle | 0.24509370 |
| 114 | MP0003122_maternal_imprinting | 0.23343602 |
| 115 | MP0001851_eye_inflammation | 0.23162511 |
| 116 | MP0005197_abnormal_uvea_morphology | 0.21374619 |
| 117 | MP0002128_abnormal_blood_circulation | 0.21100518 |
| 118 | MP0003878_abnormal_ear_physiology | 0.19247987 |
| 119 | MP0005377_hearing/vestibular/ear_phenot | 0.19247987 |
| 120 | MP0000467_abnormal_esophagus_morphology | 0.19056810 |
| 121 | MP0003172_abnormal_lysosome_physiology | 0.17828994 |
| 122 | MP0003633_abnormal_nervous_system | 0.17413339 |
| 123 | MP0003631_nervous_system_phenotype | 0.17268756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.55026597 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.34883222 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.33998904 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.73008834 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.65678594 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.43398808 |
| 7 | Xanthomatosis (HP:0000991) | 6.31515342 |
| 8 | Complement deficiency (HP:0004431) | 5.64450512 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.52461605 |
| 10 | Joint hemorrhage (HP:0005261) | 4.92674793 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.85778017 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.69562869 |
| 13 | Hyperammonemia (HP:0001987) | 4.57702120 |
| 14 | Epidermoid cyst (HP:0200040) | 4.51664932 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.44291800 |
| 16 | Hyperglycinemia (HP:0002154) | 4.32282412 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.26449461 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.25725121 |
| 19 | Ketosis (HP:0001946) | 4.20579918 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.20169597 |
| 21 | Fat malabsorption (HP:0002630) | 4.16020007 |
| 22 | Abnormality of complement system (HP:0005339) | 4.12142274 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.11366824 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.10106045 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.90968673 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 3.88656610 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.83330894 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.81108012 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.81108012 |
| 30 | Hyperglycinuria (HP:0003108) | 3.80525336 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.70568036 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.62006881 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.34945448 |
| 34 | Spontaneous abortion (HP:0005268) | 3.33632215 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.32962301 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.27430007 |
| 37 | Steatorrhea (HP:0002570) | 3.13052500 |
| 38 | Hypochromic microcytic anemia (HP:0004840) | 3.03792641 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 3.03443381 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.02738681 |
| 41 | Hepatocellular carcinoma (HP:0001402) | 3.01287107 |
| 42 | Delayed CNS myelination (HP:0002188) | 2.99715573 |
| 43 | Ketoacidosis (HP:0001993) | 2.98023786 |
| 44 | Myocardial infarction (HP:0001658) | 2.91125919 |
| 45 | Osteomalacia (HP:0002749) | 2.86705360 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.82143591 |
| 47 | Skin nodule (HP:0200036) | 2.78892245 |
| 48 | Metabolic acidosis (HP:0001942) | 2.71008592 |
| 49 | Purpura (HP:0000979) | 2.68836761 |
| 50 | Acanthocytosis (HP:0001927) | 2.66744322 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.62442575 |
| 52 | Lethargy (HP:0001254) | 2.58410858 |
| 53 | Hypoglycemic seizures (HP:0002173) | 2.55982555 |
| 54 | Glomerulonephritis (HP:0000099) | 2.55523102 |
| 55 | Abnormal gallbladder morphology (HP:0012437) | 2.52192433 |
| 56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.51846924 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.50978446 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.50978446 |
| 59 | Cholecystitis (HP:0001082) | 2.50351522 |
| 60 | Abnormal gallbladder physiology (HP:0012438) | 2.50351522 |
| 61 | Vascular calcification (HP:0004934) | 2.50183973 |
| 62 | Cholelithiasis (HP:0001081) | 2.45961519 |
| 63 | Amyloidosis (HP:0011034) | 2.45638648 |
| 64 | Spastic diplegia (HP:0001264) | 2.43074827 |
| 65 | Cerebral edema (HP:0002181) | 2.42286223 |
| 66 | Gingival bleeding (HP:0000225) | 2.39858544 |
| 67 | Gout (HP:0001997) | 2.39463003 |
| 68 | Mitral stenosis (HP:0001718) | 2.37678137 |
| 69 | Irritability (HP:0000737) | 2.34257226 |
| 70 | Neonatal onset (HP:0003623) | 2.33027771 |
| 71 | Pulmonary embolism (HP:0002204) | 2.30433827 |
| 72 | Reduced antithrombin III activity (HP:0001976) | 2.28001473 |
| 73 | Esophageal varix (HP:0002040) | 2.24741929 |
| 74 | Cardiovascular calcification (HP:0011915) | 2.21355516 |
| 75 | Fair hair (HP:0002286) | 2.20970336 |
| 76 | Arthropathy (HP:0003040) | 2.19935010 |
| 77 | Menorrhagia (HP:0000132) | 2.18603968 |
| 78 | Thrombophlebitis (HP:0004418) | 2.18564146 |
| 79 | Malnutrition (HP:0004395) | 2.17580497 |
| 80 | Hyperphosphaturia (HP:0003109) | 2.17577593 |
| 81 | Late onset (HP:0003584) | 2.15094164 |
| 82 | Pancreatitis (HP:0001733) | 2.12740953 |
| 83 | Sensorimotor neuropathy (HP:0007141) | 2.11996206 |
| 84 | Enlarged kidneys (HP:0000105) | 2.11322024 |
| 85 | Brushfield spots (HP:0001088) | 2.09480532 |
| 86 | Poikilocytosis (HP:0004447) | 2.08649207 |
| 87 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.08519085 |
| 88 | Bifid scrotum (HP:0000048) | 2.05284210 |
| 89 | Abnormality of urine glucose concentration (HP:0011016) | 2.05252085 |
| 90 | Glycosuria (HP:0003076) | 2.05252085 |
| 91 | Abnormality of the gallbladder (HP:0005264) | 2.04933023 |
| 92 | Vomiting (HP:0002013) | 2.02829026 |
| 93 | Abnormality of the Achilles tendon (HP:0005109) | 2.02386186 |
| 94 | Abnormality of iron homeostasis (HP:0011031) | 1.99782771 |
| 95 | Generalized aminoaciduria (HP:0002909) | 1.99749002 |
| 96 | Opisthotonus (HP:0002179) | 1.97382938 |
| 97 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95837208 |
| 98 | Hemorrhage of the eye (HP:0011885) | 1.95263750 |
| 99 | Rickets (HP:0002748) | 1.91623079 |
| 100 | Joint swelling (HP:0001386) | 1.87844132 |
| 101 | Elevated alkaline phosphatase (HP:0003155) | 1.87769344 |
| 102 | Abnormal cartilage morphology (HP:0002763) | 1.86166195 |
| 103 | Renal cortical cysts (HP:0000803) | 1.82407723 |
| 104 | Hyperglycemia (HP:0003074) | 1.81332706 |
| 105 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80522979 |
| 106 | Elevated hepatic transaminases (HP:0002910) | 1.80068662 |
| 107 | Nephritis (HP:0000123) | 1.80053378 |
| 108 | Hypophosphatemic rickets (HP:0004912) | 1.80036355 |
| 109 | Abnormality of proline metabolism (HP:0010907) | 1.79114720 |
| 110 | Hydroxyprolinuria (HP:0003080) | 1.79114720 |
| 111 | Neonatal hypoglycemia (HP:0001998) | 1.79100026 |
| 112 | Increased mean platelet volume (HP:0011877) | 1.77853325 |
| 113 | Alkalosis (HP:0001948) | 1.77262706 |
| 114 | Abnormal urine phosphate concentration (HP:0012599) | 1.76019817 |
| 115 | Increased serum pyruvate (HP:0003542) | 1.75294844 |
| 116 | Gangrene (HP:0100758) | 1.75099335 |
| 117 | Status epilepticus (HP:0002133) | 1.74874940 |
| 118 | Abnormal tarsal ossification (HP:0008369) | 1.73288964 |
| 119 | Abnormality of vitamin metabolism (HP:0100508) | 1.73194335 |
| 120 | Increased serum ferritin (HP:0003281) | 1.72239084 |
| 121 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.71261488 |
| 122 | Epistaxis (HP:0000421) | 1.65186014 |
| 123 | Abnormal platelet volume (HP:0011876) | 1.58678918 |
| 124 | Abnormal biliary tract physiology (HP:0012439) | 1.54324529 |
| 125 | Bile duct proliferation (HP:0001408) | 1.54324529 |
| 126 | Facial shape deformation (HP:0011334) | 1.53412837 |
| 127 | Potter facies (HP:0002009) | 1.53412837 |
| 128 | Abnormal delivery (HP:0001787) | 1.52261932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.04894887 |
| 2 | FGFR4 | 4.58571205 |
| 3 | ERN1 | 4.49374522 |
| 4 | SIK1 | 4.31952719 |
| 5 | TAOK3 | 3.28408743 |
| 6 | ERBB4 | 3.25503741 |
| 7 | INSRR | 2.99653576 |
| 8 | MAP2K4 | 2.34939791 |
| 9 | MST1R | 2.17780774 |
| 10 | PKN2 | 2.05727302 |
| 11 | MAPK11 | 2.02792151 |
| 12 | LATS1 | 1.84796115 |
| 13 | FLT3 | 1.82666374 |
| 14 | PIK3CG | 1.79250573 |
| 15 | TYK2 | 1.72335670 |
| 16 | NTRK3 | 1.71441967 |
| 17 | TRIB3 | 1.70914892 |
| 18 | DAPK2 | 1.63218938 |
| 19 | NEK9 | 1.54616954 |
| 20 | ABL2 | 1.53135427 |
| 21 | MAP3K2 | 1.49468839 |
| 22 | PTK6 | 1.47995456 |
| 23 | FRK | 1.43109578 |
| 24 | PRPF4B | 1.37921821 |
| 25 | FGFR2 | 1.30577580 |
| 26 | JAK2 | 1.27165141 |
| 27 | KDR | 1.24898021 |
| 28 | MAP3K12 | 1.19939735 |
| 29 | EIF2AK1 | 1.15539057 |
| 30 | MAP3K7 | 1.15075139 |
| 31 | PRKAA2 | 1.14542045 |
| 32 | CDK12 | 1.10399543 |
| 33 | PINK1 | 1.09146002 |
| 34 | FGFR1 | 1.07253746 |
| 35 | ERBB2 | 1.07241179 |
| 36 | GRK6 | 1.05415813 |
| 37 | TBK1 | 1.03428953 |
| 38 | PDGFRA | 1.02492918 |
| 39 | JAK1 | 1.02036698 |
| 40 | MAP2K3 | 1.00880799 |
| 41 | AKT3 | 1.00826650 |
| 42 | STK38L | 0.99655874 |
| 43 | NLK | 0.98101575 |
| 44 | MAPK4 | 0.96751434 |
| 45 | CAMKK2 | 0.96307672 |
| 46 | MAP3K14 | 0.95961371 |
| 47 | BCR | 0.92212577 |
| 48 | MAP3K3 | 0.91036931 |
| 49 | MAP3K10 | 0.90219349 |
| 50 | EPHA3 | 0.89447728 |
| 51 | PRKCZ | 0.88988256 |
| 52 | EPHB1 | 0.88117951 |
| 53 | MET | 0.87507664 |
| 54 | KSR2 | 0.86674408 |
| 55 | MAPK15 | 0.85538532 |
| 56 | MAP3K11 | 0.81646406 |
| 57 | PRKACG | 0.76761511 |
| 58 | PRKG1 | 0.76675527 |
| 59 | CDK6 | 0.76325227 |
| 60 | CAMK2G | 0.76144648 |
| 61 | MAPK12 | 0.75162169 |
| 62 | MAPKAPK3 | 0.74350610 |
| 63 | SCYL2 | 0.74048700 |
| 64 | FER | 0.73667807 |
| 65 | CSNK1D | 0.71941774 |
| 66 | CAMK1D | 0.69691623 |
| 67 | BRSK2 | 0.69576948 |
| 68 | CSNK1E | 0.69369634 |
| 69 | TIE1 | 0.69245755 |
| 70 | DYRK1B | 0.69068515 |
| 71 | RIPK1 | 0.67726771 |
| 72 | PRKACA | 0.67580907 |
| 73 | WNK4 | 0.66782403 |
| 74 | GSK3A | 0.66590238 |
| 75 | PRKAA1 | 0.66553198 |
| 76 | SGK1 | 0.65417830 |
| 77 | CSK | 0.64659595 |
| 78 | MAP2K6 | 0.61559168 |
| 79 | SGK3 | 0.61284693 |
| 80 | MYLK | 0.61006263 |
| 81 | PTK2 | 0.56848606 |
| 82 | FGFR3 | 0.56749231 |
| 83 | RPS6KA3 | 0.56303240 |
| 84 | IKBKE | 0.55991983 |
| 85 | IRAK3 | 0.54238859 |
| 86 | CSF1R | 0.53164024 |
| 87 | PRKCB | 0.52889165 |
| 88 | MAP3K6 | 0.52707736 |
| 89 | MAPK7 | 0.52590935 |
| 90 | TGFBR2 | 0.52493064 |
| 91 | MAP3K5 | 0.51386634 |
| 92 | TAOK2 | 0.50031691 |
| 93 | MAP2K1 | 0.49770278 |
| 94 | PRKCQ | 0.49069675 |
| 95 | SRC | 0.48959435 |
| 96 | CSNK1G1 | 0.48726616 |
| 97 | PDPK1 | 0.48675390 |
| 98 | MAP3K13 | 0.47986827 |
| 99 | RPS6KB1 | 0.46355221 |
| 100 | SGK2 | 0.46347306 |
| 101 | PRKACB | 0.45171822 |
| 102 | IGF1R | 0.44007497 |
| 103 | RET | 0.43966924 |
| 104 | ZAP70 | 0.43305754 |
| 105 | PKN1 | 0.42868647 |
| 106 | CSNK2A1 | 0.41511093 |
| 107 | EPHA2 | 0.40501770 |
| 108 | GRK1 | 0.40405698 |
| 109 | CDK4 | 0.39998196 |
| 110 | CSNK2A2 | 0.39099623 |
| 111 | PRKCG | 0.38656992 |
| 112 | EPHA4 | 0.38156308 |
| 113 | LATS2 | 0.37481724 |
| 114 | PBK | 0.37366482 |
| 115 | MTOR | 0.35772952 |
| 116 | EGFR | 0.35563694 |
| 117 | NEK1 | 0.33995990 |
| 118 | SGK494 | 0.33982519 |
| 119 | SGK223 | 0.33982519 |
| 120 | TNK2 | 0.32641229 |
| 121 | STK16 | 0.30889236 |
| 122 | MAP3K1 | 0.30260595 |
| 123 | ICK | 0.30231183 |
| 124 | CAMK4 | 0.29761650 |
| 125 | PDK1 | 0.29451712 |
| 126 | MAPK3 | 0.28389022 |
| 127 | PIK3CA | 0.27645589 |
| 128 | STK38 | 0.27477848 |
| 129 | CSNK1G2 | 0.27228586 |
| 130 | PRKCA | 0.25457164 |
| 131 | IRAK1 | 0.24705203 |
| 132 | PAK3 | 0.24315823 |
| 133 | CSNK1G3 | 0.23651504 |
| 134 | MAP2K2 | 0.22765475 |
| 135 | ABL1 | 0.22425824 |
| 136 | STK3 | 0.20482987 |
| 137 | BMX | 0.20061907 |
| 138 | CAMK1G | 0.18580108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.56318960 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.66341713 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.45094495 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31518871 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.10569216 |
| 6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.84877105 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68621797 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.63831988 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61210278 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56226231 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45959454 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35141199 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20005615 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13860754 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11645489 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07002350 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95190217 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91928958 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89903186 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89621213 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88382863 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85613608 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.83317308 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77922253 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77859504 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74987280 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73609565 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68840733 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67375015 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62291668 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59515130 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57117669 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55856008 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50698301 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50089882 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.46682461 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43952732 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34646442 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34392254 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34038773 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30707456 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27451402 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22348325 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22268306 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21398363 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19492306 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.18983796 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12752332 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.07591630 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05276319 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00939168 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99034820 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96958482 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96258849 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94164656 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88170378 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86514582 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80034218 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.79780902 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75786935 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70774820 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69018020 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65488346 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61199785 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51329831 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47058960 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45722595 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43863172 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.41747956 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.32748993 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26557594 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26551391 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25384258 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23439187 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.22360533 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20886113 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19441183 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16000223 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10071816 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.08461604 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01432602 |
| 82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2448557 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2364935 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2324399 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | -0.2292604 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | -0.2284140 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2241449 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2088966 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1931569 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1927300 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1882359 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | -0.1670612 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1654242 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1646622 |
| 95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1616343 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1503289 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1431299 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1406030 |
| 99 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1363894 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1351042 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1092608 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1008174 |
| 103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0997078 |
| 104 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0679792 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | -0.0588512 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0583339 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0558568 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0525321 |

